Jump To Jump To Watch View Summit Archive PSMA Imaging Therapy and Targeted Therapy in Prostate Cancer April 8, 2022 Dr. Beer delves into advanced prostate cancer therapy, including hormone refractory or castrate-resistant cases. Unveil the latest and upcoming treatments for metastatic prostate cancer as he presents cutting-edge data.This session was part of our VIRTUAL ZERO Prostate Cancer Summit, which took place from March 4 to 8, 2022.Watch Summit Session Archives At each ZERO Summit, you'll experience the Bold for Blue Awards, educational sessions, advocacy training, and more. See the video archives to find more of what you can expect to see when you join us at this year’s Summit! View Summit Archive Imaging Radiation Oncology Screening & PSA Test Videos & Webinars ZERO Prostate Cancer Summit Contributor Tomasz Beer, MD, Deputy Director Dr. Tomasz (Tom) Beer cares for men with prostate cancer at OHSU and at the Portland VA Medical Center. Dr. Beer was formerly a professor of medicine and Grover C. Bagby Endowed Chair for Prostate Cancer Research in the Division of Hematology and Medical Oncology, where he led the Prostate Cancer Research Program, encompassing basic research, translational research, clinical trials of novel therapeutic strategies in prostate cancer, and studies aimed at enhancing cancer survivorship More for you
Dr. Beer delves into advanced prostate cancer therapy, including hormone refractory or castrate-resistant cases. Unveil the latest and upcoming treatments for metastatic prostate cancer as he presents cutting-edge data.This session was part of our VIRTUAL ZERO Prostate Cancer Summit, which took place from March 4 to 8, 2022.Watch
Summit Session Archives At each ZERO Summit, you'll experience the Bold for Blue Awards, educational sessions, advocacy training, and more. See the video archives to find more of what you can expect to see when you join us at this year’s Summit! View Summit Archive
